Cross-tolerance and enhanced sensitivity to the response rate-decreasing effects of opioids with varying degrees of efficacy at the mu receptor
- PMID: 1663253
- DOI: 10.1007/BF02244364
Cross-tolerance and enhanced sensitivity to the response rate-decreasing effects of opioids with varying degrees of efficacy at the mu receptor
Abstract
The purpose of the present experiment was to determine whether the effects of opioids with varying degrees of efficacy at the mu receptor are differentially altered in morphine-tolerant pigeons. To this end, dose-effect curves were determined for high, intermediate, and low efficacy mu agonists in pigeons responding under a schedule of food presentation prior to, during, and after exposure to a regimen of chronic morphine administration. In pigeons treated with 56 mg/kg/daily morphine, the dose-effect curves for the rate-decreasing effects of the high-efficacy mu agonists morphine and fentanyl were shifted to the right of their prechronic positions (i.e., tolerance). A small degree of tolerance was also conferred to the intermediate-efficacy mu agonists (-)-pentazocine and (-)-metazocine, but not to nalbuphine or butorphanol. In contrast to the effects obtained with these mu agonists, the chronic morphine regimen shifted the dose-effects curves of the mu antagonist naloxone and the low-efficacy mu agonists nalorphine and levallorphan to the left of their prechronic positions (i.e., enhanced sensitivity). These findings demonstrate that morphine tolerance confers cross-tolerance to other high efficacy mu agonists, enhanced sensitivity to mu antagonists and low efficacy mu agonists, and little or no cross-tolerance to intermediate efficacy mu agonists. Disadvantages of using schedule-controlled responding to examine the effects of intermediate efficacy mu agonists are discussed.
Similar articles
-
Differential cross-tolerance to mu and kappa opioid agonists in morphine-tolerant rats responding under a schedule of food presentation.Psychopharmacology (Berl). 1991;103(1):129-35. doi: 10.1007/BF02244087. Psychopharmacology (Berl). 1991. PMID: 1848712
-
Intermediate efficacy mu opioids: examination of their morphine-like stimulus effects and response rate-decreasing effects in morphine-tolerant rats.J Pharmacol Exp Ther. 1992 Nov;263(2):668-81. J Pharmacol Exp Ther. 1992. PMID: 1331411
-
Acute and chronic morphine administration: effects of mixed-action opioids in rats and squirrel monkeys responding under a schedule of food presentation.J Pharmacol Exp Ther. 1991 Apr;257(1):8-18. J Pharmacol Exp Ther. 1991. PMID: 1850479
-
Effects of narcotics and narcotic antagonists on operant behavior.Adv Biochem Psychopharmacol. 1973;8(0):345-59. Adv Biochem Psychopharmacol. 1973. PMID: 4604406 Review. No abstract available.
-
Opioid agonist-antagonist drugs in acute and chronic pain states.Drugs. 1991 Mar;41(3):326-44. doi: 10.2165/00003495-199141030-00002. Drugs. 1991. PMID: 1711441 Review.
Cited by
-
Abuse-related effects of µ-opioid analgesics in an assay of intracranial self-stimulation in rats: modulation by chronic morphine exposure.Behav Pharmacol. 2013 Sep;24(5-6):459-70. doi: 10.1097/FBP.0b013e328364c0bd. Behav Pharmacol. 2013. PMID: 23881045 Free PMC article.
-
Enhancement of Opioid Antinociception by Nicotine.J Pharmacol Exp Ther. 2019 Dec;371(3):624-632. doi: 10.1124/jpet.119.261438. Epub 2019 Sep 16. J Pharmacol Exp Ther. 2019. PMID: 31527281 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials